CD226 and neoplasm: First of all, CAR NK cells may conjugate the killing activity based on CAR-specific mechanisms with their spontaneous tumor cytotoxic capability, mediated by receptors such as NKp46, NKp44, NKp30, NKG2D, and DNAM-1 (CD226) [105].